FIGURE 1.

Dexamethasone treatment increases the promoter activity of phAGT2.6-luc as compared with phAGT1.2-luc upon transient transfection in HepG2 and HK-2 cells. HepG2 (A) or HK-2 cells (B) were transiently transfected with reporter construct phAGT1.2-luc (open bar) or phAGT2.6-luc (filled bar) and RSV-GR. After 24 h, cells were treated in the absence or presence of 100 nm Dex as described under “Materials and Methods.” Luciferase activity was determined after 24 h of Dex treatment. Error bars, S.E.